Worldwide Market for Women’s Pharmaceuticals to Top $63 Billion by 2010

New York, August 3, 2006 — Unprecedented advancements in the area of women’s health and worldwide recognition of the importance of addressing conditions that overwhelmingly affect women, underscore a pharmaceutical coup that by the end of 2010 could see manufacturing giants partaking in a revenue pot worth nearly $64 billion.

According to Women’s Health: Worldwide Prescription Drug Markets, a new study released today from Kalorama Information, 2005 revenues for therapeutics addressing women’s needs, such as autoimmune diseases, cancer, and menopause, among others, exceeded $45 billion. Indeed, from 2000 to 2005, the market grew by 10.5%, with 2005 seeing strongest sales in the gynecological infections and STDs segment realizing almost $12 billion in revenues, 25.9% of the overall market.

Certainly the bright spot on the horizon of women’s health is the recent approval of a new cervical cancer vaccine, inaugurating a vaccine market potentially worth several billion dollars a year. The vaccine helps prevent infection from sexually transmitted strains of human papillomavirus (HPV), which causes the cancer. Similarly, the emergence of a possible vaccine-type treatment to prevent AIDS—currently in the testing phase—has shown great promise for women around the world.

While sales of hormone replacement drugs fell sharply from 2002 to 2004 on the heels of much publicized reports of the adverse health effects of long term HRT treatment, sales in most other segments have continued to show positive trends, according to the report.

“We’re seeing the fruits of 25 years of increased advocacy and public awareness campaigns focusing on women’s health,” notes Mary Anne Crandall, the report’s author. “Rapid advances in women-specific drug discovery will not only transform this market, but continue to grow it as the need for advanced treatments escalates among the aging female population.”

This 4th Edition of Women’s Health: Worldwide Prescription Drug Markets includes research and development pipelines; in-depth company profiles; four-region geographic breakdowns; and market size, growth, and share for the following product categories: autoimmune diseases; cancer; gynecological and STDs; hormones; osteoporosis; and urinary disorders. It is available directly from Kalorama Information at:

http://www.bioportfolio.com/cgi-bin/acatalog/Women_s_Health__Worldwide_Prescription_Drug_Markets.html

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. To view their catalogue go to:

http://www.bioportfolio.com/cgi-bin/acatalog/Kalorama.html